ESR1 and androgen insensitivity syndrome: Reactivation of ESR1 signaling in concave paraspinal muscle by selective estrogen receptor modulator Raloxifene has been introduced as a potential treatment strategy to alleviate the curve progression in our previous study,16 and the current study further indicated the importance of targeting asymmetrical expression of ESR1 to treat AIS from a clinical perspective.